Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer
暂无分享,去创建一个
N. Ueno | D. Tripathy | C. Bartholomeusz | B. Lim | Jangsoon Lee | Kuicheon Choi | T. Pearson | L. Paradiso | J. Fuson | Thomas W. Myers